α<sub>1</sub>-Acid Glycoprotein and Dietary Intake in End-Stage Renal Disease Patients

Management of end-stage renal disease (ESRD) patients requires monitoring each of the components of malnutrition–inflammation–atherosclerosis (MIA) syndrome. Restrictive diet can negatively affect nutritional status and inflammation. An acute-phase protein—α<sub>1</sub>-acid glycoprotein...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Małgorzata Maraj, Paulina Hetwer, Beata Kuśnierz-Cabala, Barbara Maziarz, Paulina Dumnicka, Marek Kuźniewski, Piotr Ceranowicz
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/d7ea58797d5b4ef0a0920994210d4d51
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d7ea58797d5b4ef0a0920994210d4d51
record_format dspace
spelling oai:doaj.org-article:d7ea58797d5b4ef0a0920994210d4d512021-11-25T18:33:00Zα<sub>1</sub>-Acid Glycoprotein and Dietary Intake in End-Stage Renal Disease Patients10.3390/nu131136712072-6643https://doaj.org/article/d7ea58797d5b4ef0a0920994210d4d512021-10-01T00:00:00Zhttps://www.mdpi.com/2072-6643/13/11/3671https://doaj.org/toc/2072-6643Management of end-stage renal disease (ESRD) patients requires monitoring each of the components of malnutrition–inflammation–atherosclerosis (MIA) syndrome. Restrictive diet can negatively affect nutritional status and inflammation. An acute-phase protein—α<sub>1</sub>-acid glycoprotein (AGP), has been associated with energy metabolism in animal and human studies. The aim of our study was to look for a relationship between serum AGP concentrations, laboratory parameters, and nutrient intake in ESRD patients. The study included 59 patients treated with maintenance hemodialysis. A 24 h recall assessed dietary intake during four non-consecutive days—two days in the post-summer period, and two post-winter. Selected laboratory tests were performed: complete blood count, serum iron, total iron biding capacity (TIBC) and unsaturated iron biding capacity (UIBC), vitamin D, AGP, C-reactive protein (CRP), albumin, prealbumin, and phosphate–calcium metabolism markers (intact parathyroid hormone, calcium, phosphate). Recorded dietary intake was highly deficient. A majority of patients did not meet recommended daily requirements for energy, protein, fiber, iron, magnesium, folate, and vitamin D. AGP correlated positively with CRP (R = 0.66), platelets (R = 0.29), and negatively with iron (R = −0.27) and TIBC (R = −0.30). AGP correlated negatively with the dietary intake of plant protein (R = −0.40), potassium (R = −0.27), copper (R = −0.30), vitamin B<sub>6</sub> (R = −0.27), and folates (R = −0.27), p < 0.05. However, in multiple regression adjusted for confounders, only CRP was significantly associated with AGP. Our results indicate that in hemodialyzed patients, serum AGP is weakly associated with dietary intake of several nutrients, including plant protein.Małgorzata MarajPaulina HetwerBeata Kuśnierz-CabalaBarbara MaziarzPaulina DumnickaMarek KuźniewskiPiotr CeranowiczMDPI AGarticlehemodialysisend-stage kidney diseasemalnutritiondietary intakeα<sub>1</sub>-acid glycoproteinappetiteNutrition. Foods and food supplyTX341-641ENNutrients, Vol 13, Iss 3671, p 3671 (2021)
institution DOAJ
collection DOAJ
language EN
topic hemodialysis
end-stage kidney disease
malnutrition
dietary intake
α<sub>1</sub>-acid glycoprotein
appetite
Nutrition. Foods and food supply
TX341-641
spellingShingle hemodialysis
end-stage kidney disease
malnutrition
dietary intake
α<sub>1</sub>-acid glycoprotein
appetite
Nutrition. Foods and food supply
TX341-641
Małgorzata Maraj
Paulina Hetwer
Beata Kuśnierz-Cabala
Barbara Maziarz
Paulina Dumnicka
Marek Kuźniewski
Piotr Ceranowicz
α<sub>1</sub>-Acid Glycoprotein and Dietary Intake in End-Stage Renal Disease Patients
description Management of end-stage renal disease (ESRD) patients requires monitoring each of the components of malnutrition–inflammation–atherosclerosis (MIA) syndrome. Restrictive diet can negatively affect nutritional status and inflammation. An acute-phase protein—α<sub>1</sub>-acid glycoprotein (AGP), has been associated with energy metabolism in animal and human studies. The aim of our study was to look for a relationship between serum AGP concentrations, laboratory parameters, and nutrient intake in ESRD patients. The study included 59 patients treated with maintenance hemodialysis. A 24 h recall assessed dietary intake during four non-consecutive days—two days in the post-summer period, and two post-winter. Selected laboratory tests were performed: complete blood count, serum iron, total iron biding capacity (TIBC) and unsaturated iron biding capacity (UIBC), vitamin D, AGP, C-reactive protein (CRP), albumin, prealbumin, and phosphate–calcium metabolism markers (intact parathyroid hormone, calcium, phosphate). Recorded dietary intake was highly deficient. A majority of patients did not meet recommended daily requirements for energy, protein, fiber, iron, magnesium, folate, and vitamin D. AGP correlated positively with CRP (R = 0.66), platelets (R = 0.29), and negatively with iron (R = −0.27) and TIBC (R = −0.30). AGP correlated negatively with the dietary intake of plant protein (R = −0.40), potassium (R = −0.27), copper (R = −0.30), vitamin B<sub>6</sub> (R = −0.27), and folates (R = −0.27), p < 0.05. However, in multiple regression adjusted for confounders, only CRP was significantly associated with AGP. Our results indicate that in hemodialyzed patients, serum AGP is weakly associated with dietary intake of several nutrients, including plant protein.
format article
author Małgorzata Maraj
Paulina Hetwer
Beata Kuśnierz-Cabala
Barbara Maziarz
Paulina Dumnicka
Marek Kuźniewski
Piotr Ceranowicz
author_facet Małgorzata Maraj
Paulina Hetwer
Beata Kuśnierz-Cabala
Barbara Maziarz
Paulina Dumnicka
Marek Kuźniewski
Piotr Ceranowicz
author_sort Małgorzata Maraj
title α<sub>1</sub>-Acid Glycoprotein and Dietary Intake in End-Stage Renal Disease Patients
title_short α<sub>1</sub>-Acid Glycoprotein and Dietary Intake in End-Stage Renal Disease Patients
title_full α<sub>1</sub>-Acid Glycoprotein and Dietary Intake in End-Stage Renal Disease Patients
title_fullStr α<sub>1</sub>-Acid Glycoprotein and Dietary Intake in End-Stage Renal Disease Patients
title_full_unstemmed α<sub>1</sub>-Acid Glycoprotein and Dietary Intake in End-Stage Renal Disease Patients
title_sort α<sub>1</sub>-acid glycoprotein and dietary intake in end-stage renal disease patients
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/d7ea58797d5b4ef0a0920994210d4d51
work_keys_str_mv AT małgorzatamaraj asub1subacidglycoproteinanddietaryintakeinendstagerenaldiseasepatients
AT paulinahetwer asub1subacidglycoproteinanddietaryintakeinendstagerenaldiseasepatients
AT beatakusnierzcabala asub1subacidglycoproteinanddietaryintakeinendstagerenaldiseasepatients
AT barbaramaziarz asub1subacidglycoproteinanddietaryintakeinendstagerenaldiseasepatients
AT paulinadumnicka asub1subacidglycoproteinanddietaryintakeinendstagerenaldiseasepatients
AT marekkuzniewski asub1subacidglycoproteinanddietaryintakeinendstagerenaldiseasepatients
AT piotrceranowicz asub1subacidglycoproteinanddietaryintakeinendstagerenaldiseasepatients
_version_ 1718411048209350656